DaVita/DVA

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About DaVita

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

Ticker

DVA

Sector

Healthcare

Trading on

NYSE

Industry

Health Care Providers and Services

Headquarters

Denver, United States

Employees

70,000

DaVita Metrics

BasicAdvanced
$12B
Market cap
15.73
P/E ratio
$8.80
EPS
1.05
Beta
-
Dividend rate
$12B
1.05
1.426
1.296
429.156
449.224
3.42%
6.36%
43.22%
15.73
1.01
13.07
-1.86
13.56
5.77%
60.50%
2.29%
10.80%

What the Analysts think about DaVita

Analyst Ratings

Majority rating from 8 analysts.
Hold

DaVita Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
7.80% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$3.1B
-2.39%
Net income
$240M
59.10%
Profit margin
7.80%
63.18%

DaVita Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 35.74%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$1.91
$2.62
$1.62
$2.65
-
Expected
$1.69
$2.02
$1.59
$1.95
$2.48
Surprise
12.80%
29.92%
1.67%
35.74%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for DaVita stock?

DaVita (DVA) has a market cap of $12B as of July 03, 2024.

What is the P/E ratio for DaVita stock?

The price to earnings (P/E) ratio for DaVita (DVA) stock is 15.73 as of July 03, 2024.

Does DaVita stock pay dividends?

No, DaVita (DVA) stock does not pay dividends to its shareholders as of July 03, 2024.

When is the next DaVita dividend payment date?

DaVita (DVA) stock does not pay dividends to its shareholders.

What is the beta indicator for DaVita?

DaVita (DVA) has a beta rating of 1.05. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell DaVita stock

Buy or sell DaVita stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing